Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Essential Properties Realty Trust Files Investor Presentation

Essential Properties Realty Trust, Inc. filed a Form 8-K with the SEC on September 14, 2026, disclosing the release of an investor presentation intended for use in meetings with investors.

Aditi Sarkar | 14 September 2026

Definium Therapeutics Reports Phase 3 Panorama Topline Data

Definium Therapeutics, Inc. filed a Form 8-K with the SEC on September 14, 2026, disclosing positive topline data from its Phase 3 Panorama study of DT120 ODT for the treatment of generalized anxiety disorder, along with an accompanying investor presentation posted to the company's …

Aakashdeep | 14 September 2026

Eos Energy Secures $87 Million Third DOE Loan Advance

Eos Energy Enterprises, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on September 14, 2026, disclosing that the Federal Financing Bank funded a third advance of $87,018,601 under its DOE-guaranteed promissory note on September 10, 2026.

Anjali Anand | 14 September 2026

Graco Appoints Richard B. Lewis to Board of Directors

Graco Inc. filed a Form 8-K on September 14, 2026, disclosing that its Board of Directors appointed Richard B. Lewis as a new director, effective December 3, 2026, with an assignment to the Audit Committee.

Manish Choudhary | 14 September 2026

Rimini Street Reinstates Chief Revenue Officer

Rimini Street, Inc. filed a Form 8-K on September 14, 2026, disclosing the reinstatement of Steven Hershkowitz as Executive Vice President and Chief Revenue Officer, effective the same date, following his previously reported resignation on September 8, 2026.

Aakashdeep | 14 September 2026

Bowman Consulting Go-Shop Period Expires in Merger Deal

Bowman Consulting Group Ltd. filed a current report on Form 8-K on September 14, 2026, disclosing that the "go-shop" period established under its previously announced Agreement and Plan of Merger with Prive Parent, Inc. and Prive Merger Sub, Inc. has expired.

Anjali Anand | 14 September 2026

Summit Therapeutics Reports HARMONi-2 Phase III Updated Data Presentation

Summit Therapeutics Inc. filed a Form 8-K on September 14, 2026, disclosing that its partner Akeso Inc. announced the presentation of updated data, including overall survival, from the Phase III HARMONi-2 trial at the International Association for the Study of Lung Cancer's 2026 World …

Vinay Lochav | 14 September 2026

Hyperliquid Strategies Amends Stock Purchase Agreement

Hyperliquid Strategies Inc filed a Form 8-K on September 14, 2026, disclosing that it entered into Amendment No. 2 to its ChEF Purchase Agreement with Chardan Capital Markets LLC, revising the per-share purchase price terms for common stock sales under the agreement.

Aditi Sarkar | 14 September 2026

A10 Networks Appoints Mary C. Henry to Board of Directors

A10 Networks, Inc. filed a Form 8-K with the SEC on September 14, 2026, disclosing the appointment of Mary C. Henry as a new member of its Board of Directors, effective October 5, 2026.

Vinay Lochav | 14 September 2026

TransDigm Launches Tender Offer for 6.75% Notes Due 2028

TransDigm Group Incorporated filed a Form 8-K with the SEC on September 14, 2026, disclosing that its wholly-owned subsidiary TransDigm Inc. has commenced a cash tender offer for any and all of its outstanding 6.75% Senior Secured Notes due 2028.

Manish Choudhary | 14 September 2026
Support

Hi! How can we help you today?

Loading…